▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Apogee Therapeutics (NASDAQ: APGE)

$53.21

(12.6%)

$5.97

Price as of October 9, 2025, 4:00 p.m. ET

Apogee Therapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
APGE	-1.92%			+123%
S&P	+16.28%	+93.70%	+14.13%	+49%

Apogee Therapeutics Company Info

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in February 2022 and is headquartered in Waltham, MA.

News & Analysis

Featured Article

Why Apogee Therapeutics Stock Triumphed on Thursday

The company aims to raise gross proceeds of roughly $300 million in a new capital-raising effort.

Eric Volkman | Oct 9, 2025

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services